Moving to Mounjaro 5mg: what to expect from your second pen

You've just finished your 2.5mg pen, here's what changes at 5mg

Picture the moment: your fourth injection at 2.5mg is done, your prescriber has reviewed your progress, and a plain box arrives via DPD with the 5mg KwikPen inside. The pen looks almost identical to the one you started on. But inside, the dose is doubled, and most people notice that within days of their first 5mg injection.

The 2.5mg dose exists almost entirely to let your system acclimatise. Nausea, slow digestion, a changed appetite, your body is meeting tirzepatide for the first time. The job of that first pen is adjustment, not treatment. At 5mg, the medicine begins doing more of what it is licensed for: activating GIP and GLP-1 receptors to slow gastric emptying, signal fullness earlier in a meal, and regulate the hormonal side of appetite. For a thorough overview of how the full dose range fits together, the Mounjaro dose guide covers each step in context.

In the SURMOUNT-1 trial, participants who reached the higher maintenance doses saw average body-weight reductions of around 20–21% over 72 weeks, with 5mg being one of the rungs on that ladder rather than a destination in itself for most people. The trial is published in the New England Journal of Medicine and remains the primary evidence base for tirzepatide's weight-management effects.

Progression through the schedule isn't automatic. A prescriber reviews how you've managed the previous dose before authorising the next one. That review matters, it's the mechanism that keeps the titration safe.

Side effects that can intensify at 5mg, and what usually happens next

Gastrointestinal side effects are the most commonly reported at any tirzepatide dose, and a step-up to 5mg of Mounjaro can bring a temporary flare. Nausea is the most frequent complaint; constipation, loose stools, reflux and a feeling of persistent fullness are also well-documented. The NHS patient information for tirzepatide notes these are generally most prominent after starting or after each dose increase, and they typically ease within days to a couple of weeks for most people.

A few practical things reduce the impact. Eating smaller portions (which the medicine itself tends to encourage) helps. So does staying well-hydrated, especially if nausea has been suppressing your appetite for fluids. High-fat meals tend to worsen symptoms; many people find lighter protein-led eating more comfortable at the start of a new dose.

There are side effects that warrant prompt medical attention at any dose: severe, persistent stomach pain that reaches through to your back could indicate pancreatitis, and you should seek help the same day rather than waiting to see if it passes. Signs of an allergic reaction, significant dehydration from vomiting, or any symptom that concerns you should go to your prescriber or GP, not the internet. You can also report suspected side effects directly at the MHRA's Yellow Card scheme.

Most people who get through the first week or two at 5mg find the side-effect picture settles considerably. That's been the consistent pattern across the tirzepatide clinical programme.

How long does 5mg last, and what comes after?

Each Mounjaro pen contains four weekly doses. At 5mg, that means one pen covers four weeks of treatment, the same cadence as every other strength in the range. The once-weekly injection is taken on the same day each week, with each pen stored in the fridge between uses.

For most people following the licensed titration schedule, 5mg is not a long-term maintenance dose. The full schedule runs from 2.5mg through to 15mg, with prescribers typically assessing tolerance before each step upward. How quickly someone moves through depends on individual response, some people stay longer at a given dose because they're managing side effects; some reach their maintenance dose more quickly. That decision sits with the prescriber at each review. The 5mg dose page goes deeper on what the clinical review at this stage typically involves.

For context on what Mounjaro costs at different doses as treatment progresses, the Mounjaro price comparison sets out how private pricing typically works across the dose range, useful reading before you reach the higher strengths.

After 5mg, the schedule moves to 7.5mg. If you're curious about what changes at that point, the 7.5mg page covers it. And if you want to revisit how the journey started, the 2.5mg page explains the role of that first pen in detail.

Who can be prescribed Mounjaro 5mg, and how does that work privately?

Eligibility for Mounjaro as a licensed medicine covers adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related health condition such as high blood pressure, high cholesterol, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. The full eligibility picture is covered on the Mounjaro treatment overview.

Being eligible in principle isn't the same as being prescribed 5mg specifically. At that dose, you've already been on treatment for at least four weeks. The prescriber reviewing your repeat is checking that you've tolerated 2.5mg adequately and that progressing is clinically appropriate for you. The NHS tirzepatide page gives patients an accessible overview of the medicine and what to expect from each phase of treatment.

At nume, every repeat order (including the step to 5mg) is reviewed by a GPhC-registered Independent Prescriber. That review happens the same day, based on your reported experience and any clinical information we hold. It's not automated. If the assessment supports progression, the pen is dispatched with free next-working-day delivery. If you have questions about how that process works, the treatment page walks through each step, and our prescribers are reachable seven days a week.